
"Sector" = median of Healthcare across 84 companies
Zimmer Biomet Holdings, Inc. is a global leader in musculoskeletal healthcare, designing, manufacturing, and marketing orthopedic products and surgical solutions. The company specializes in reconstructive implants for hips, knees, shoulders, and elbows, as well as sports medicine, biologics, and trauma products. It also offers dental implants and spine-related devices. Headquartered in Warsaw, Indiana, Zimmer Biomet operates in over 25 countries and serves healthcare professionals worldwide.
The company generates revenue primarily from the sale of orthopedic implants, instruments, and related surgical supplies. Its business model relies on long-term relationships with hospitals, surgeons, and distributors, often through consignment inventories and direct sales forces. Key revenue segments include Knees (largest), Hips, and S.E.T. (Sports Medicine, Extremities, Trauma, and other). Recurring revenue from disposables and instruments also contributes. Zimmer Biomet invests heavily in R&D to innovate new products and procedures.
Zimmer Biomet operates in the highly competitive medical devices industry, specifically the orthopedic market. It is one of the top three players globally, alongside Johnson & Johnson (DePuy Synthes) and Stryker. The industry is characterized by high barriers to entry due to regulatory approvals, patent protection, and the need for clinical evidence. The company differentiates itself through a broad product portfolio, strong brand recognition, and a focus on robotic-assisted surgery (e.g., Rosa platform) and digital solutions. Growth drivers include aging populations and increasing demand for joint replacements.
The primary customers are orthopedic surgeons, hospitals, ambulatory surgical centers, and dental professionals. Zimmer Biomet's products are used in elective surgeries, trauma cases, and dental restoration. Geographically, the United States is the largest market (over 60% of revenue), followed by Europe, Asia-Pacific, and emerging markets. The company's target audience includes aging baby boomers and active individuals requiring joint repair or replacement. Its products are sold in over 100 countries through direct sales and distributor networks.
An auto-generated descriptive profile based on company data, for informational purposes only.
No 24-hour summary has been generated yet.
Latest saved period: March 2026 · 2026-03-31
Cash dividends by ex-date, not an investment recommendation.
| Ex-date | Amount | Payment date | Period |
|---|---|---|---|
| Mar 31, 2026 | $0.24 | Apr 30, 2026 | Quarterly |
| Dec 30, 2025 | $0.24 | Jan 30, 2026 | Quarterly |
| Sep 30, 2025 | $0.24 | Oct 31, 2025 | Quarterly |
| Jun 26, 2025 | $0.24 | Jul 31, 2025 | Quarterly |
| Mar 31, 2025 | $0.24 | Apr 30, 2025 | Quarterly |
| Dec 30, 2024 | $0.24 | Jan 31, 2025 | Quarterly |
| Sep 30, 2024 | $0.24 | Oct 31, 2024 | Quarterly |
| Jun 26, 2024 | $0.24 | Jul 31, 2024 | Quarterly |
| Mar 27, 2024 | $0.24 | Apr 30, 2024 | Quarterly |
| Dec 26, 2023 | $0.24 | Jan 31, 2024 | Quarterly |
| Sep 28, 2023 | $0.24 | Oct 31, 2023 | Quarterly |
| Jun 23, 2023 | $0.24 | Jul 31, 2023 | Quarterly |
| Mar 28, 2023 | $0.24 | Apr 28, 2023 | Quarterly |
| Dec 23, 2022 | $0.24 | Jan 31, 2023 | Quarterly |
| Sep 29, 2022 | $0.24 | Oct 31, 2022 | Quarterly |
| Jun 24, 2022 | $0.24 | Jul 29, 2022 | Quarterly |
| Mar 28, 2022 | $0.24 | Apr 29, 2022 | Quarterly |
| Dec 27, 2021 | $0.23 | Jan 31, 2022 | Quarterly |
| Sep 29, 2021 | $0.23 | Oct 29, 2021 | Quarterly |
| Jun 25, 2021 | $0.23 | Jul 30, 2021 | Quarterly |
| Mar 26, 2021 | $0.23 | Apr 30, 2021 | Quarterly |
| Dec 24, 2020 | $0.23 | Jan 29, 2021 | Quarterly |
| Sep 29, 2020 | $0.23 | Oct 30, 2020 | Quarterly |
| Jun 26, 2020 | $0.23 | Jul 31, 2020 | Quarterly |
Wrqti brings Zimmer Biomet Holdings, Inc. data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Companies in the Healthcare sector you can compare with Zimmer Biomet Holdings, Inc.:
When available, the page shows quarterly and annual statements plus ratios such as PE, price to book, profit margin, and free cash flow. Latest financial period shown: March 2026.
Wrqti content depends on available data and third-party sources and may include delays or errors. Review official company filings and consult a licensed financial advisor before making investment decisions. Read the data methodology.